Clinical Trial Update: Allopurinol and Pathogenesis of Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating allopurinol for the pathogenesis of cirrhosis has completed. The study was sponsored by Tanta University and targete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

Sponsor: Tanta University | Conditions: Cirrhoses, Liver | Phase 1, Phase 2 | Status: COMPLETED